POSTER SESSION

Poster 101
‘Liquid/emulsion drug delivery system (LEDDS™) formulation for oral vaccination’
E.A. McNeela, J. Bryant, I. Coulter and E.C. Lavelle (Trinity College Dublin and Sigmoid Biotechnologies Ltd., Ireland)

Poster 102
‘Plant origin stress induced proteins – natural adjuvants’
T. Jaliashvili, R. Iannacone, S. Summerer and F. Bruno (Biorational Technology France Ltd., Dreux, France)

Poster 103
‘Comparative efficacy of mucosal adjuvants for virus-like particle vaccine’
Fu Shi Quan et al. (Emory University, Atlanta, Georgia, USA)

Poster 104
‘Vaccination trial using a recombinant Mannheimia vaccine in goats’
M.Y. Sabri and M. Zamri-Saad (University Putra, Selangor, Malaysia)

Poster 105
‘Determination of saccharide contents in Hib vaccines by high performance anion-exchange chromatography with pulsed amperometric detection’
Hye Na Kang et al. (Korea Food & Drug Administration, Seoul, Korea)

Poster 106
‘Live attenuated salmonella as a mucosal vector vaccine for Campylobacter’
Thomas A. Luijkx et al. (Nobilon, Schering-Plough, Boxmeer, The Netherlands)

Poster 107
‘Neonatal BCG vaccination: enhanced protective effects in adult after boosting with mycobacterial heparin-binding hemagglutinin (HBHA)’
Carmen Fernandez et al. (Stockholm University, Sweden)

Poster 108
‘Antibodies induced by mucosal immunization of mice with Lactobacillus casei expressing different intimin fragments are able to inhibit the adhesion of enteropathogenic Escherchia coli to epithelial cells’
Paulo L. Ho et al. (Instituto Butantan, Sao Paulo, Brazil)

Poster 109
‘Liposomal adjuvant on intranasal vaccination of chickens against Newcastle disease’
Li-Ping Tseng et al. (National Taiwan University, Taiwan)

Poster 110
‘Immune response against Brucella abortus Cu-Zn superoxide dismutase expressed in Lactococcus lactis as mucosal vaccine’
Edilia Andrews et al. (Universidade de Concepcion, Chile)

Poster 111
‘Plant seeds as bioreactors for the production of high-value proteins’
Annelies De Paepe et al. (Ghent University, Belgium)

Poster 112
‘Influence of solvent during synthesis of WGA-conjugated Gantrez® AN 119 nanoparticles for delivery of antigens’
Katrien VanDamme et al. (Ghent University, Belgium)

Poster 113
‘Nanoparticles of alginate and chitosan: a potential oral DNA vaccine delivery system’
Lidia M.D. Goncalves et al. (Universidade de Lisboa, Portugal)

Poster 114
‘Adsorbed microparticulate vaccine against equine strangles’
Antonio J. Almeida et al. (Universidade de Lisboa, Portugal)

Poster 115
‘A tonsillar polyICLC/AT-2 SIV therapeutic vaccine maintains low viremia in infected Rhesus macaques following antiretroviral therapy cessation’
Panagiotis Vagenas et al. (HIV/AIDS Program, Population Council, New York, USA)

Poster 116
‘A tonsillar CpG-C ISS ODN/AT-2 SIV based vaccine for SIV partially protects Rhesus macaques from rectal SIVmac239 challenge’
Panagiotis Vagenas et al. (HIV/AIDS Program, Population Council, New York, USA)

Poster 117
‘Characterization of the immune response to novel
B. Pertussis vaccine formulations’ Aleksandra Gracia et al. (VIDO, University of Saskatchewan, Saskatoon, Canada)

Poster 118
‘Development of an oral influenza vaccine using lipid vesicles’
Ewan Bennett et al. (University of Strathclyde, Glasgow, UK)

Poster 119
‘Role of intestinal microbiota in the efficacy of an oral antileishmanial vaccine using germ-free mice’
B. Rossi-Bergmann et al. (Federal University of Rio de Janeiro, Brazil)

Poster 120
‘Influence of retinol on the effectiveness of the oral LaAg vaccine against cutaneous leishmaniasis’
B. Rossi-Bergmann et al. (Federal University of Rio de Janeiro, Brazil)

Poster 121
‘Porous pellets as carriers of F4 fimbriae used for oral vaccination of suckling piglets against entertoxigenic Escherchia coli infections’
P. Bellot et al. (Ghent University, Belgium)

Poster 122
‘Mucosal immunomodulation for neurodegenerative diseases’
Fernando Goni et al (New University School of Medicine, New York, USA)

Poster 123
‘Protective properties of MC 1220 incorporated into liposome against intravaginal challenge of Rhesus Macaques with RT-SHIV’
Melanie Caron et al. (CIRMF, Franceville, Gabon)

Poster 124
‘A comprehensive study of plant-derived HSP70 ailmed to vaccine formulations’
Selene Baschieri et al. (ENEA, Rome, Italy)

Poster 125
‘Arming artichoke mottled crinkle virus coat protein with immunogenic epitopes’
Carla Marusic et al. (ENEA Rome, Italy)

Poster 126
‘Immune response in chicken vaccinated with mucosal Newcastle disease vaccines’
I.A. Runina et al. (FGI ‘ARRIAH’, Vladimir, Russia)

Poster 127
‘Induction of protective immunity against avian influenza using recombinant adenovirus CELO, carrying subtype H5 hemagglutinin gene’
M.L. Shulpin et al. (FGI ‘ARRIAH’, Vladimir, Russia)

Poster 128
‘Chitosan based nanoparticles for oral administration of hepatitis B antigen’
Olga Borges et al. (University of Coimbra, Portugal)